Page
%P
-
Article
Are quality-adjusted medical prices declining for chronic disease? Evidence from diabetes care in four health systems
Improvements in medical treatment have contributed to rising health spending. Yet there is relatively little evidence on whether the spending increase is “worth it” in the sense of producing better health outc...
-
Article
Assessing Taiwan’s pay-for-performance program for diabetes care: a cost–benefit net value approach
Pay-for-Performance (P4P) to better manage chronic conditions has yielded mixed results. A better understanding of the cost and benefit of P4P is needed to improve program assessment. To this end, we assessed ...